oxidopamine hydrochloride has been researched along with zpck in 1 studies
| Studies (oxidopamine hydrochloride) | Trials (oxidopamine hydrochloride) | Recent Studies (post-2010) (oxidopamine hydrochloride) | Studies (zpck) | Trials (zpck) | Recent Studies (post-2010) (zpck) |
|---|---|---|---|---|---|
| 18 | 0 | 13 | 31 | 0 | 17 |
| Protein | Taxonomy | oxidopamine hydrochloride (IC50) | zpck (IC50) |
|---|---|---|---|
| Chymase | Homo sapiens (human) | 0.4 | |
| Cysteine protease ATG4B | Homo sapiens (human) | 1.965 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for oxidopamine hydrochloride and zpck
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |